Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer

Lin Ding(Anhui Medical University), Yong‐Guan Zhu(Research Center for Eco-Environmental Sciences)
Journal of Experimental & Clinical Cancer Research
March 25, 2024
Cited by 10


Related Papers